Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 671

1.

MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study.

Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Embleton N, Graham R, Hart AR, Jarvis D, Kilby MD, Lie M, Mason G, Mandefield L, Mooney C, Pennington R, Robson SC, Wailoo A.

Health Technol Assess. 2019 Sep;23(49):1-144. doi: 10.3310/hta23490.

2.

Long-term cognitive outcomes in tuberous sclerosis complex.

Tye C, Mcewen FS, Liang H, Underwood L, Woodhouse E, Barker ED, Sheerin F, Yates JRW, Bolton PF; Tuberous Sclerosis 2000 Study Group.

Dev Med Child Neurol. 2019 Sep 19. doi: 10.1111/dmcn.14356. [Epub ahead of print]

PMID:
31538337
3.

An explanation for posttransplant late-onset disease associated with CMV prophylaxis.

Griffiths PD.

Rev Med Virol. 2019 Sep;29(5):e2080. doi: 10.1002/rmv.2080. Epub 2019 Aug 19. No abstract available.

PMID:
31429170
4.

The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation.

Gomes AC, Griffiths PD, Reeves MB.

Vaccines (Basel). 2019 Jul 17;7(3). pii: E67. doi: 10.3390/vaccines7030067. Review.

5.

Variation in prognosis given by fetomaternal units in fetuses with neurological abnormalities.

Hart A, Embleton N, Mooney C, Bradburn M, Griffiths PD.

Arch Dis Child Fetal Neonatal Ed. 2019 Jul 4. pii: fetalneonatal-2019-317517. doi: 10.1136/archdischild-2019-317517. [Epub ahead of print] No abstract available.

6.

Natural history studies bring universal screening for congenital CMV infection closer.

Griffiths PD.

Rev Med Virol. 2019 Jul;29(4):e2072. doi: 10.1002/rmv.2072. Epub 2019 Jun 24. No abstract available.

PMID:
31237046
7.

The rate of brain abnormalities on in utero MRI studies in fetuses with normal ultrasound examinations of the brain and calculation of indicators of diagnostic performance.

Griffiths PD, Bradburn M, Mandefield L, Mooney C, Jarvis D.

Clin Radiol. 2019 Jul;74(7):527-533. doi: 10.1016/j.crad.2019.03.010. Epub 2019 Apr 12.

PMID:
30987757
8.

T2 prolongation in the cerebellar vermis on prenatal MRI of fetuses with Chiari 2 malformations.

Warner HM, Batty R, Warner FM, Fanou EM, Griffiths PD.

Clin Radiol. 2019 May;74(5):408.e19-408.e25. doi: 10.1016/j.crad.2019.01.001. Epub 2019 Feb 26.

PMID:
30824110
9.

An integrated in utero MR method for assessing structural brain abnormalities and measuring intracranial volumes in fetuses with congenital heart disease: results of a prospective case-control feasibility study.

Griffiths PD, Mousa HA, Finney C, Mooney C, Mandefield L, Chico TJA, Jarvis D.

Neuroradiology. 2019 May;61(5):603-611. doi: 10.1007/s00234-019-02184-2. Epub 2019 Feb 22.

10.

Assessment of brain perfusion using hyperpolarized 129 Xe MRI in a subject with established stroke.

Rao MR, Norquay G, Stewart NJ, Hoggard N, Griffiths PD, Wild JM.

J Magn Reson Imaging. 2019 Sep;50(3):1002-1004. doi: 10.1002/jmri.26686. Epub 2019 Feb 18. No abstract available.

PMID:
30779261
11.

Turning cost effectiveness analysis on its head.

Griffiths PD.

Rev Med Virol. 2019 Mar;29(2):e2040. doi: 10.1002/rmv.2040. Epub 2019 Feb 7. No abstract available.

PMID:
30734398
12.

Normative volume measurements of the fetal intra-cranial compartments using 3D volume in utero MR imaging.

Jarvis DA, Finney CR, Griffiths PD.

Eur Radiol. 2019 Jul;29(7):3488-3495. doi: 10.1007/s00330-018-5938-5. Epub 2019 Jan 25.

13.

"He looks gorgeous" - iuMR images and the transforming of foetal and parental identities.

Lie M, Graham R, Robson SC, Griffiths PD.

Sociol Health Illn. 2019 Feb;41(2):360-377. doi: 10.1111/1467-9566.12831. Epub 2018 Nov 18.

PMID:
30450603
14.

Viral disease of the year: Anterior uveitis.

Griffiths PD.

Rev Med Virol. 2018 Nov;28(6):e2015. doi: 10.1002/rmv.2015. Epub 2018 Oct 24. No abstract available.

PMID:
30353994
15.

Current state of MRI of the fetal brain in utero.

Jarvis DA, Griffiths PD.

J Magn Reson Imaging. 2019 Mar;49(3):632-646. doi: 10.1002/jmri.26316. Epub 2018 Oct 24. Review.

PMID:
30353990
16.

Schizencephaly revisited.

Griffiths PD.

Neuroradiology. 2018 Sep;60(9):945-960. doi: 10.1007/s00234-018-2056-7. Epub 2018 Jul 19.

17.

Analysis of errors made on in utero MR studies of the foetal brain in the MERIDIAN study.

Batty R, Gawne-Cain ML, Mooney C, Mandefield L, Bradburn M, Mason G, Griffiths PD.

Eur Radiol. 2019 Jan;29(1):195-201. doi: 10.1007/s00330-018-5508-x. Epub 2018 Jun 15.

18.

Cytomegalovirus vaccine: timing is important.

Griffiths PD.

Rev Med Virol. 2018 Jul;28(4):e1986. doi: 10.1002/rmv.1986. Epub 2018 Jun 19. No abstract available.

PMID:
29921027
19.

Do opportunistic viruses hunt in packs?

Griffiths PD.

Rev Med Virol. 2018 May;28(3):e1982. doi: 10.1002/rmv.1982. No abstract available.

PMID:
29738116
20.

Initial experience of an investigational 3T MR scanner designed for use on neonatal wards.

Griffiths PD, Jarvis D, Armstrong L, Connolly DJA, Bayliss P, Cook J, Hart AR, Pilling E, Williams T, Paley MNJ.

Eur Radiol. 2018 Oct;28(10):4438-4446. doi: 10.1007/s00330-018-5357-7. Epub 2018 Apr 30.

21.

Brain-injured Survivors of Monochorionic Twin Pregnancies Complicated by Single Intrauterine Death: MR Findings in a Multicenter Study.

Conte G, Righini A, Griffiths PD, Rustico M, Lanna M, Mackie FL, Pinelli L, Prefumo F, Persico N, Igra MS, Parazzini C, Doneda C, Fichera A, Ambrosi C, Kilby M, Severino M, Triulzi F, Rossi A, Skipper N.

Radiology. 2018 Aug;288(2):582-590. doi: 10.1148/radiol.2018171267. Epub 2018 Apr 24.

PMID:
29688161
22.

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.

Baraniak I, Kropff B, Ambrose L, McIntosh M, McLean GR, Pichon S, Atkinson C, Milne RSB, Mach M, Griffiths PD, Reeves MB.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6273-6278. doi: 10.1073/pnas.1800224115. Epub 2018 Apr 23.

23.

MRI for Fetal Developmental Brain Abnormalities: Perspectives From the Pregnant Patient.

Lie MLS, Graham RH, Robson SC, Griffiths PD; MERIDIAN Collaborative Group.

Qual Health Res. 2018 Jul;28(8):1295-1307. doi: 10.1177/1049732318764390. Epub 2018 Mar 26.

PMID:
29580171
24.

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia.

Baraniak I, Kropff B, McLean GR, Pichon S, Piras-Douce F, Milne RSB, Smith C, Mach M, Griffiths PD, Reeves MB.

J Infect Dis. 2018 May 25;217(12):1907-1917. doi: 10.1093/infdis/jiy102.

25.

Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient.

Baraniak IA, Reeves MB, Griffiths PD.

Rev Med Virol. 2018 Jan;28(1). doi: 10.1002/rmv.1958. Epub 2017 Nov 17. Review.

PMID:
29148608
26.

Is Dr von Magnus to blame for the withdrawal of live attenuated influenza vaccine?

Griffiths PD.

Rev Med Virol. 2018 Jan;28(1). doi: 10.1002/rmv.1962. Epub 2017 Nov 15. No abstract available.

PMID:
29143392
27.

Cytomegalovirus is still in intensive care.

Griffiths PD.

Rev Med Virol. 2017 Nov;27(6). doi: 10.1002/rmv.1957. Epub 2017 Nov 15. No abstract available.

PMID:
29143387
28.

Should we perform in utero MRI on a fetus at increased risk of a brain abnormality if ultrasonography is normal or shows non-specific findings?

Griffiths PD, Mooney C, Bradburn M, Jarvis D.

Clin Radiol. 2018 Feb;73(2):123-134. doi: 10.1016/j.crad.2017.09.007. Epub 2017 Oct 16. Review.

29.

Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort.

Ramsay ID, Attwood C, Irish D, Griffiths PD, Kyriakou C, Lowe DM.

J Clin Virol. 2017 Nov;96:73-79. doi: 10.1016/j.jcv.2017.09.013. Epub 2017 Oct 3. Review.

PMID:
29017084
30.

Herpesviruses and the Hayflick Limit In Vivo.

Griffiths PD.

J Infect Dis. 2017 Sep 1;216(5):511-513. doi: 10.1093/infdis/jix256. No abstract available.

31.

Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.

Griffiths PD, Rothwell E, Raza M, Wilmore S, Doyle T, Harber M, O'Beirne J, Mackinnon S, Jones G, Thorburn D, Mattes F, Nebbia G, Atabani S, Smith C, Stanton A, Emery VC.

PLoS One. 2017 Sep 19;12(9):e0185298. doi: 10.1371/journal.pone.0185298. eCollection 2017.

32.

Imaging Human Brain Perfusion with Inhaled Hyperpolarized 129Xe MR Imaging.

Rao MR, Stewart NJ, Griffiths PD, Norquay G, Wild JM.

Radiology. 2018 Feb;286(2):659-665. doi: 10.1148/radiol.2017162881. Epub 2017 Aug 31.

PMID:
28858563
33.

Disruption of gastrointestinal integrity in patients with HIV infection.

Griffiths PD.

Rev Med Virol. 2017 Jul;27(4). doi: 10.1002/rmv.1935. No abstract available.

PMID:
28677223
34.

Anatomical subgroup analysis of the MERIDIAN cohort: failed commissuration.

Griffiths PD, Brackley K, Bradburn M, Connolly DJA, Gawne-Cain ML, Griffiths DI, Kilby MD, Mandefield L, Mooney C, Robson SC, Vollmer B, Mason G.

Ultrasound Obstet Gynecol. 2017 Dec;50(6):753-760. doi: 10.1002/uog.17502. Epub 2017 Nov 3.

35.

Anatomical subgroup analysis of the MERIDIAN cohort: posterior fossa abnormalities.

Griffiths PD, Brackley K, Bradburn M, Connolly DJA, Gawne-Cain ML, Kilby MD, Mandefield L, Mooney C, Robson SC, Vollmer B, Mason G.

Ultrasound Obstet Gynecol. 2017 Dec;50(6):745-752. doi: 10.1002/uog.17485. Epub 2017 Nov 8.

36.

Clinical applications of 3D volume MR imaging of the fetal brain in utero.

Jarvis D, Griffiths PD.

Prenat Diagn. 2017 Jun;37(6):556-565. doi: 10.1002/pd.5042. Epub 2017 May 15.

PMID:
28370255
37.

Anatomical subgroup analysis of the MERIDIAN cohort: ventriculomegaly.

Griffiths PD, Brackley K, Bradburn M, Connolly DJA, Gawne-Cain ML, Griffiths DI, Kilby MD, Mandefield L, Mooney C, Robson SC, Vollmer B, Mason G.

Ultrasound Obstet Gynecol. 2017 Dec;50(6):736-744. doi: 10.1002/uog.17475. Epub 2017 Nov 5.

38.

Virology in a "post-truth" world.

Griffiths PD.

Rev Med Virol. 2017 May;27(3):e1928. doi: 10.1002/rmv.1928. Epub 2017 Mar 20. No abstract available.

PMID:
28318120
39.

Change in diagnostic confidence brought about by using in utero MRI for fetal structural brain pathology: analysis of the MERIDIAN cohort.

Griffiths PD, Bradburn M, Campbell MJ, Connolly DJA, Cooper CL, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC, Wailoo A; MERIDIAN Collaborative Group.

Clin Radiol. 2017 Jun;72(6):451-457. doi: 10.1016/j.crad.2017.01.009. Epub 2017 Feb 24.

40.

Making dollars and sense out of a screening programme.

Griffiths PD.

Rev Med Virol. 2017 Mar;27(2). doi: 10.1002/rmv.1925. Epub 2017 Feb 7. No abstract available.

PMID:
28170131
41.

In utero MR imaging in fetuses at high risk of lissencephaly.

Williams F, Griffiths PD.

Br J Radiol. 2017 Apr;90(1072):20160902. doi: 10.1259/bjr.20160902. Epub 2017 Mar 3.

42.

The assessment of fetal brain growth in diabetic pregnancy using in utero magnetic resonance imaging.

Paddock M, Akram R, Jarvis DA, Armitage P, Song S, Madhuvrata P, Griffiths PD.

Clin Radiol. 2017 May;72(5):427.e1-427.e8. doi: 10.1016/j.crad.2016.12.004. Epub 2017 Jan 3.

43.

Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study.

Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Graham R, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC, Wailoo A; MERIDIAN collaborative group.

Lancet. 2017 Feb 4;389(10068):538-546. doi: 10.1016/S0140-6736(16)31723-8. Epub 2016 Dec 15.

44.

Medical practice driven by legislators rather than by regulators.

Griffiths PD.

Rev Med Virol. 2017 Jan;27(1). doi: 10.1002/rmv.1922. Epub 2016 Dec 15. No abstract available.

PMID:
27977042
45.

Quantification of total fetal brain volume using 3D MR imaging data acquired in utero.

Jarvis D, Akram R, Mandefield L, Paddock M, Armitage P, Griffiths PD.

Prenat Diagn. 2016 Dec;36(13):1225-1232. doi: 10.1002/pd.4961. Epub 2016 Nov 29.

46.

A qualitative comparison of arterial spin labelling and dynamic susceptibility contrast MRI in 52 children with a range of neurological conditions.

Armitage PA, Skipper N, Connolly DJ, Griffiths PD.

Br J Radiol. 2017 Jan;90(1069):20160495. doi: 10.1259/bjr.20160495. Epub 2016 Nov 18.

47.

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD; Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum.

Clin Infect Dis. 2017 Jan 1;64(1):87-91. Epub 2016 Sep 28.

PMID:
27682069
48.

Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.

Griffiths PD, Rothwell E, Raza M, Wilmore S, Doyle T, Harber M, O'Beirne J, Mackinnon S, Jones G, Thorburn D, Mattes F, Nebbia G, Atabani S, Smith C, Stanton A, Emery VC.

PLoS One. 2016 Sep 29;11(9):e0163722. doi: 10.1371/journal.pone.0163722. eCollection 2016. Erratum in: PLoS One. 2017 Sep 19;12 (9):e0185298.

49.

A systematic review and meta-analysis to determine the contribution of mr imaging to the diagnosis of foetal brain abnormalities In Utero.

Jarvis D, Mooney C, Cohen J, Papaioannou D, Bradburn M, Sutton A, Griffiths PD.

Eur Radiol. 2017 Jun;27(6):2367-2380. doi: 10.1007/s00330-016-4563-4. Epub 2016 Sep 21. Review.

50.

Compartmentalized dynamics of cytomegalovirus replication in treated congenital infection.

Luck SE, Emery VC, Atkinson C, Sharland M, Griffiths PD.

J Clin Virol. 2016 Sep;82:152-158. doi: 10.1016/j.jcv.2016.07.018. Epub 2016 Jul 27.

PMID:
27500364

Supplemental Content

Loading ...
Support Center